ARCHIVES

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 7 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO

May 25, 2007

NCAB Approves Fallout Study On Split Vote

March 13, 1981

Indiana to Close Proton Beam Facility Amid Nationwide Building Boom

October 17, 2014

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

March 30, 2001

In Brief: Fisher, Moore, Metcalf to Share Hammer Prize; NCAB Hearing On Organ Systems Program Dec. 3

October 30, 1987

‘Helping Smokers Quit’ Program Launched By NCI, Pharmacist Group

June 27, 1986